Waaree Renewable Technologies shares surged 667% in 4 months but recently fell 68% due to a double-top pattern. Analysts ...

Mankind Pharma's domestic business revenues grew by 16 per cent year-on-year, reaching Rs 2,773 crore in Q3FY25, compared to Rs 2,400 crore in Q3FY24. The company’s consumer healthcare segment saw a ...

Extending losses for the second session, Dr Reddy’s shares dropped 6.65% to hit a low of ₹1,203.60 on the BSE as investors weighed weak Q3 results.

UltraTech Cement shares rose 1% following strong Q3 results, with a 17% YoY profit decline but revenue exceeding estimates.

By the second day of subscription, the IPO had already received a massive 50.63 times subscription, with bids for 26,58,10,750 shares against the 52,50,000 shares on offer.

Dr Reddy’s shares tumbled up to 6% in early trade and at 9:46 am, they were trading 4.35% lower at Rs 1,233.25 on the Bombay Stock Exchange (BSE).

Goldman Sachs reportedly has maintained a 'Buy' rating and increased its target price to Rs 12,580, up from Rs 12,460, citing volume recovery and lower costs contributing to margin improvement ...

Axis Securities recommends BUY for the target of Rs 315. Robust order book, leading supplier of defence equipment and further ...

The Dr Agarwal’s Health Care IPO is a combination of fresh issuance of equity shares worth Rs 300 crore, and an offer-for-sale of 6.78 crore shares by the existing shareholders.

Strides Pharma share price has fallen over 10% in one month and 16% in three months. However, Strides Pharma stock has ...

Coforges shares ended Thursdays trading session on the BSE 11.86% higher at Rs 9200.80 per share, with a market value of Rs ...

Public sector shipyard Mazagaon Dockyards Limited (MDL) on Thursday said it has been invited by the Defence Ministry from ...